Using AI to improve genetic engineering techniques
Harmony AI: State of the Art Natural Language Processing for Genetic Engineering
This study is exploring new ways to improve how genes are engineered, which could help create better and safer treatments like vaccines and gene therapies for patients.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cfd Research Corporation NIH-funded |
| Lab location | 1 site (Huntsville, United States) |
| Project ID | NIH-10698805 on NIH RePORTER |
What this research studies
This research focuses on enhancing gene engineering through advanced natural language processing techniques. By analyzing how synonymous codons are utilized in organisms like E. coli, the project aims to optimize protein production while minimizing potential negative effects on protein function. The approach involves using artificial intelligence to predict codon usage patterns, which could lead to safer and more effective therapeutic applications, including vaccines and gene therapies. Patients may benefit from improved treatments that are developed using these optimized genetic engineering techniques.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from advanced gene therapies or protein-based treatments, particularly those with genetic disorders or conditions requiring innovative therapeutic approaches.
Not a fit: Patients with conditions that do not involve genetic therapies or protein-based treatments may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer gene therapies and protein-based medications for patients.
How similar studies have performed: Other research has shown promise in using computational techniques for gene optimization, but this specific AI-driven approach is relatively novel.
Where this research is happening
Huntsville, United States
- Cfd Research Corporation — Huntsville, United States (Active)
Researchers
- Principal investigator: Gaddes, David — Cfd Research Corporation
- Study coordinator: Gaddes, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.